Healthcare

Blood Coagulants Market Valuable Growth Prospects, Top Players, Key Country Analysis, Trends and Forecast till 2023

Press Release

Blood Coagulants Market Information, By Types (Coagulation Factor, others), By Indication (Haemophilia, Surgery, other Bleeding Disorders – Middle East & Africa Forecast till 2023

Market analysis

Coagulation is the procedure, by which blood changes from a fluid to a gel, shaping blood coagulation. Generally speaking, coagulation is a particular process in which the blood frames clumps to blocks and afterward mend a sore/injury/cut and pause the bleeding. In Sub-Saharan Africa and the Middle East, bleeding issues has now become a common problem as there is a limited number of proper screening and treatment processes. Also, people living there are ignorant about this disease which is one of the major cause for the people suffering from a bleeding disorder. The Middle East and Africa blood coagulant market development is significantly ascribed to expanding pervasiveness of the bleeding issue, rising subsidizing, insurance protection cover, and various awareness programs for bleeding issue. However, the lack of research and development capabilities, lack of awareness among the public and the presence of the counterfeit drugs are some of the major factors hindering the market growth. The MEA blood coagulants market is expected to grow at a CAGR of 9.5% during the forecast period 2017-2023.

Market segmentation

The MEA blood coagulants market is divided on the basis of its indications, types, and by country.

On the basis of its indication, the market is bifurcated into surgery, haemophilia, and other bleeding disorders. Based on its types, the market is classified into coagulation factor and others.

Regional analysis

Based on its country, the market is divided into UAE, KSA, Qatar, Kuwait, Oman, Egypt, and the Rest of Middle East & Africa.

Major players

Some of the major industry players in the MEA blood coagulants market includes brands like Bayer AG (Germany), Pfizer Inc. (U.S.), Novo Nordisk AS (Dernmark), SOBI (Sweden), Octapharma (Switzerland), Shire (Republic of Ireland), CSL Limited (Australia), among others.

Get more information, Ask for free sample copy: https://www.reportocean.com/industry-verticals/sample-request.php?report_id=19266

Table of Contents:

1            Report Prologue

2            Research Methodology

2.1         Research Process

2.2         Primary Research

2.3         Secondary Research

2.4         Market Size Estimation

2.5         Forecast Model

3            Market Dynamics

3.1         Introduction

3.2         Drivers

3.2.1     Bleeding disorder and related conditions will push the demands on health systems (Impact weightage 75%)

3.2.2     Rising funding, healthcare insurance coverage, and awareness programs for bleeding disorders are expected to boost the growth of the market (Impact weightage 25%)

3.3         Restrains

3.3.1     Lack of R&D capabilities: (Impact weightage 45%)

3.3.2     Counterfeit Drugs (Impact weightage 35%)

3.3.3     Lack of Awareness (Impact weightage 20%)

4            Middle East & Africa Blood Coagulants Market By Type

4.1         Introduction

4.2         Coagulation Factor

4.2.1     Recombinant Coagulation Factor

4.2.2     Plasma Derived Coagulation Factor

5            Middle East & Africa Blood Coagulants Market, By Indication

5.1         Introduction

5.2         Haemophilia

5.3         Surgery

5.4         Other Bleeding Disorders

6            Middle East & Africa Blood Coagulants Market, By Country

6.1         Introduction

6.2         Saudi Arabia (KSA)

6.3         United Arab Emirates (UAE)

6.4         Qatar

6.5         Oman

6.6         Kuwait

6.7         Egypt

6.8         Rest of Middle East & Africa

7            Company Profiles

7.1         Pfizer

7.1.1     Company Overview

7.1.2     Financials

7.1.3     Products

7.1.4     Strategies

7.1.5     Key Developments

7.2         Bayer AG

7.2.1     Company Overview

7.2.2     Financials

7.2.3     Products

7.2.4     Strategies

7.2.5     Key Developments

7.3         Novo Nordisk AS

7.3.1     Company Overview

7.3.2     Financials

7.3.3     Products

7.3.4     Strategies

7.3.5     Key Developments

7.4         Shire

7.4.1     Company Overview

7.4.2     Financials

7.4.3     Products

7.4.4     Strategies

7.5         SOBI

7.5.1     Company Overview

7.5.2     Financials

7.5.3     Products

7.5.4     Strategies

7.5.5     Key Developments

7.6         Octapharma

7.6.1     Company Overview

7.6.2     Financials

7.6.3     Products

7.6.4     Strategies

7.6.5     Key Developments

7.7         CSL Limited

7.7.1     Company Overview

7.7.2     Financials

7.7.3     Products

7.7.4     Strategies

7.7.5     Key Developments

List of Tables:

TABLE 1 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD Million)

TABLE 2 MIDDLE EAST & AFRICA COAGULATION FACTOR MARKET BY TYPE, 2014 TO 2023 (USD Million)

TABLE 3 MIDDLE EAST & AFRICA COAGULATION FACTOR MARKET BY COUNTRIES, 2014 TO 2023 (USD Million)

TABLE 4 MIDDLE EAST & AFRICA RECOMBINANT COAGULATION FACTOR MARKET BY COUNTRIES, 2014 TO 2023 (USD Million)

TABLE 5 MIDDLE EAST & AFRICA PLASMA DERIVED COAGULATION FACTOR MARKET BY COUNTRIES, 2014 TO 2023 (USD Million)

TABLE 6 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET BY INDICATION, 2014 TO 2023 (USD Million)

TABLE 7 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET FOR HAEMOPHILIA BY COUNTRY, 2014 TO 2023 (USD Million)

TABLE 8 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET FOR SURGERY BY COUNTRY, 2014 TO 2023 (USD Million)

TABLE 9 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET FOR OTHER BLEEDING DISORDERS BY COUNTRY, 2014 TO 2023 (USD Million)

TABLE 10            MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET, BY COUNTRY, 2014 TO 2023 (USD Million)

TABLE 11            SAUDI ARABIA BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD Million)

TABLE 12            SAUDI ARABIA COAGULATION FACTOR MARKET BY TYPE, 2014 TO 2023 (USD Million)

TABLE 13            SAUDI ARABIA BLOOD COAGULANTS MARKET BY INDICATION, 2014 TO 2023 (USD Million)

TABLE 14            UNITED ARAB EMIRATES BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD Million)

TABLE 15            UNITED ARAB EMIRATES COAGULATION FACTOR MARKET BY TYPE, 2014 TO 2023 (USD Million)

TABLE 16            UNITED ARAB EMIRATES BLOOD COAGULANTS MARKET BY INDICATION, 2014 TO 2023 (USD Million)

TABLE 17            QATAR BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD Million)

TABLE 18            QATAR COAGULATION FACTOR MARKET BY TYPE, 2014 TO 2023 (USD Million)

TABLE 19            QATAR BLOOD COAGULANTS MARKET BY INDICATION, 2014 TO 2023 (USD Million)

TABLE 20            OMAN BLOOD COAGULANTS MARKET BY TYPE, 2014 TO 2023 (USD Million)

Continue……

Access this Report: https://www.reportocean.com/industry-verticals/sample-request.php?report_id=19266

 

About us:

We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom-line goals which will boost your market share in today’s competitive environment. Report Ocean is ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports. We will help you in finding the upcoming trends that will entitle you as a leader in the industry. We are here to work with you on your objective which will create an immense opportunity for your organization.

Contact us:
Company Name: Report Ocean
Address: Classic Tower, Rajnagar Extension, Ghaziabad, 201017 – India
Contact: +1 888 212 3539 (US) +91-9997112116 (Outside US)
Contact Person: Sandeep Singh
URL: www.reportocean.com
Email: [email protected]